Sophiris Bio Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,000.00
-
-
-
-
2
Cost of Goods Sold (COGS) incl. D&A
84.00
47.00
20.00
12.00
4.00
2
Gross Income
4,916.00
47.00
20.00
12.00
4.00
2
SG&A Expense
14,706.00
29,993.00
13,468.00
8,694.00
11,914.00
15,137
EBIT
9,790.00
30,040.00
13,488.00
8,706.00
11,918.00
15,139
Unusual Expense
689.00
49.00
-
2,110.00
3,307.00
8,690
Non Operating Income/Expense
240.00
46.00
41.00
12.00
48.00
22
Interest Expense
1,308.00
726.00
690.00
373.00
207.00
684
Pretax Income
10,649.00
30,712.00
14,197.00
11,164.00
8,628.00
6,778
Income Tax
500.00
-
-
-
-
-
Consolidated Net Income
11,149.00
30,712.00
14,197.00
11,164.00
8,628.00
6,778
Net Income
11,149.00
30,712.00
14,197.00
11,164.00
8,628.00
6,778
Net Income After Extraordinaries
11,149.00
30,712.00
14,197.00
11,164.00
8,628.00
6,778
Net Income Available to Common
11,149.00
30,712.00
14,197.00
11,164.00
8,628.00
6,778
EPS (Basic)
1.39
1.85
0.84
0.49
0.29
0.23
Basic Shares Outstanding
8,029.00
16,586.00
16,881.00
23,002.00
30,111.00
30,115
EPS (Diluted)
1.39
1.85
0.84
0.49
0.29
0.23
Diluted Shares Outstanding
8,029.00
16,586.00
16,881.00
23,002.00
30,111.00
30,115
EBITDA
9,706.00
29,993.00
13,468.00
8,694.00
11,914.00
15,137
Non-Operating Interest Income
-
51.00
22.00
37.00
238.00
333
About Sophiris Bio
View Profile
